These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 31593802)
1. CD44(+) tumor cells promote early angiogenesis in head and neck squamous cell carcinoma. Ludwig N; Szczepanski MJ; Gluszko A; Szafarowski T; Azambuja JH; Dolg L; Gellrich NC; Kampmann A; Whiteside TL; Zimmerer RM Cancer Lett; 2019 Dec; 467():85-95. PubMed ID: 31593802 [TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas. Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606 [TBL] [Abstract][Full Text] [Related]
3. Targeting HIF-1α/NOTCH1 pathway eliminates CD44 Byun JY; Huang K; Lee JS; Huang W; Hu L; Zheng X; Tang X; Li F; Jo DG; Song X; Huang C Oncogene; 2022 Feb; 41(9):1352-1363. PubMed ID: 35013621 [TBL] [Abstract][Full Text] [Related]
4. CD24+ tumor-initiating cells from oral squamous cell carcinoma induce initial angiogenesis in vivo. Zimmerer RM; Ludwig N; Kampmann A; Bittermann G; Spalthoff S; Jungheim M; Gellrich NC; Tavassol F Microvasc Res; 2017 Jul; 112():101-108. PubMed ID: 28344048 [TBL] [Abstract][Full Text] [Related]
5. Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells. Gomez KE; Wu F; Keysar SB; Morton JJ; Miller B; Chimed TS; Le PN; Nieto C; Chowdhury FN; Tyagi A; Lyons TR; Young CD; Zhou H; Somerset HL; Wang XJ; Jimeno A Cancer Res; 2020 Oct; 80(19):4185-4198. PubMed ID: 32816856 [TBL] [Abstract][Full Text] [Related]
6. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells. Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336 [TBL] [Abstract][Full Text] [Related]
7. CD44 as a stem cell marker in head and neck squamous cell carcinoma. Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876 [TBL] [Abstract][Full Text] [Related]
8. Exosomes from HNSCC Promote Angiogenesis through Reprogramming of Endothelial Cells. Ludwig N; Yerneni SS; Razzo BM; Whiteside TL Mol Cancer Res; 2018 Nov; 16(11):1798-1808. PubMed ID: 30042174 [TBL] [Abstract][Full Text] [Related]
9. UBE2C promotes the progression of head and neck squamous cell carcinoma. Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550 [TBL] [Abstract][Full Text] [Related]
10. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. Bourguignon LYW; Earle C; Shiina M Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080 [TBL] [Abstract][Full Text] [Related]
11. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma. Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862 [TBL] [Abstract][Full Text] [Related]
12. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma. Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623 [TBL] [Abstract][Full Text] [Related]
13. Characterization of FaDu-R, a radioresistant head and neck cancer cell line, and cancer stem cells. Cho KJ; Park EJ; Kim MS; Joo YH Auris Nasus Larynx; 2018 Jun; 45(3):566-573. PubMed ID: 28844650 [TBL] [Abstract][Full Text] [Related]
14. Lymphotoxin-α promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner. Yang JG; Wang WM; Xia HF; Yu ZL; Li HM; Ren JG; Chen G; Wang BK; Jia J; Zhang W; Zhao YF Int J Cancer; 2019 Sep; 145(5):1358-1370. PubMed ID: 30785217 [TBL] [Abstract][Full Text] [Related]
15. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas. Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653 [TBL] [Abstract][Full Text] [Related]
16. ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC. Kamarajan P; Shin JM; Qian X; Matte B; Zhu JY; Kapila YL Cancer Med; 2013 Dec; 2(6):793-802. PubMed ID: 24403253 [TBL] [Abstract][Full Text] [Related]
17. Microvessel density in head and neck squamous cell carcinoma. Szafarowski T; Sierdzinski J; Szczepanski MJ; Whiteside TL; Ludwig N; Krzeski A Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1845-1851. PubMed ID: 29748768 [TBL] [Abstract][Full Text] [Related]
18. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma. Geng S; Guo Y; Wang Q; Li L; Wang J Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma. Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811 [TBL] [Abstract][Full Text] [Related]
20. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties. Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]